These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7190724)

  • 1. Selective protection in BALB/c mice against Meth A sarcoma induced by normal allogeneic tissues from H-2 congeneic mice.
    García-Olivares E; Garrido F
    Rev Esp Fisiol; 1980 Jun; 36(2):215-6. PubMed ID: 7190724
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor rejection antigens of the chemically induced BALB/c Meth A sarcoma.
    DeLeo AB
    Immunol Ser; 1994; 61():31-6. PubMed ID: 8011753
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.
    Coggin JH
    Mol Biother; 1989; 1(4):223-8. PubMed ID: 2818874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The soluble antigens of BALB/c sarcoma Meth-A: a relationship between a serologically defined tumor-specific surface antigen (TSSA) and the tumor-associated transplantation antigen (TATA).
    DuBois GC; Appella E; Law LW; DeLeo AB; Old LJ
    Transplant Proc; 1981 Dec; 13(4):1765-73. PubMed ID: 6173944
    [No Abstract]   [Full Text] [Related]  

  • 5. Specific antigens on methylcholanthrene-induced tumors of mice.
    Lennox ES; Lowe AD; Cohn J; Evan G
    Transplant Proc; 1981 Dec; 13(4):1759-61. PubMed ID: 6173943
    [No Abstract]   [Full Text] [Related]  

  • 6. [Histocompatibility antigens of 2 transplantable reticulum cell tumors TRH 3 and TRBL 3 (induced in BALB/c/Cb/Se and C57BL/Cb/Se mice with ascites mammary carcinoma ATPC+). I. Transplantability tests].
    Maltzeff N
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1975; 35(1):29-41. PubMed ID: 1243772
    [No Abstract]   [Full Text] [Related]  

  • 7. Properties of a M(r) 110,000 tumor rejection antigen of the chemically induced BALB/c Meth A sarcoma.
    De Leo AB; Becker M; Lu L; Law LW
    Cancer Res; 1993 Apr; 53(7):1602-7. PubMed ID: 7680955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte.
    Frassanito MA; Mayordomo JI; DeLeo RM; Storkus WJ; Lotze MT; DeLeo AB
    Cancer Res; 1995 Jan; 55(1):124-8. PubMed ID: 7528638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-H-2 foreign alloantigens on chemically induced sarcoma cells as detected by graft-versus-host reaction [proceedings].
    Parmiani G; Invernizzi G
    Folia Biol (Praha); 1976; 22(6):395-6. PubMed ID: 12029
    [No Abstract]   [Full Text] [Related]  

  • 10. possible role of a retrovirus in the expression of tumor-specific antigens of the Meth A sarcoma.
    DeLeo AB; Chang KS; Wivel NA; Appella E; Old LJ; Law LW
    Int J Cancer; 1982 Jun; 29(6):687-93. PubMed ID: 7107069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of identity between TSTA and alien antigens of methylcholanthrene-induced murine sarcomas.
    Parmiani G
    Transplant Proc; 1980 Mar; 12(1):50-2. PubMed ID: 7368293
    [No Abstract]   [Full Text] [Related]  

  • 12. [Transplantation immunity to a UV-induced murine sarcoma by injection of a glycoprotein fraction from the tumor].
    Pasternak L; Ristau E
    Arch Geschwulstforsch; 1985; 55(1):17-21. PubMed ID: 3985765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cloned class I MHC-restricted, CD8+ anti-Meth A cytotoxic T-lymphocytes: recognition of an epitope derived from the Meth A gp110 tumor rejection antigen.
    Fassanito MA; Loftus D; De Leo RM; Law LW; Appella E; De Leo AB
    Cancer Res; 1994 Aug; 54(16):4424-9. PubMed ID: 7519121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation between tumour resistance and delayed-type hypersensitivity to tumour-associated antigens in the mouse.
    Henderson DC; Parker D; Turk JL
    Immunology; 1980 Jan; 39(1):1-9. PubMed ID: 7380461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface expression of alien hybrid IE/C antigens on the reticulum cell sarcoma of SJL/J mice.
    Bonavida B; Wilbur SM; Marelli O
    Transplant Proc; 1981 Dec; 13(4):1833-6. PubMed ID: 7036479
    [No Abstract]   [Full Text] [Related]  

  • 16. Assignment of the gene encoding for Meth A tumour rejection antigen (TATA) to chromosome 12 of the mouse.
    Law LW
    Br J Cancer; 1984 Jul; 50(1):109-11. PubMed ID: 6743507
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunogenetic study of tumor growth in inbred rats].
    Urizar LA; Ballina JC; Amerio N; Morini JC; Rabasa SL
    Medicina (B Aires); 1982; 42(4):403-8. PubMed ID: 15171022
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of bone marrow cells in the growth inhibition of transplanted methylcholanthrene-induced sarcoma (MCA).
    Scuderi P; Rosse C
    Transplant Proc; 1981 Mar; 13(1 Pt 2):747-51. PubMed ID: 7268893
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenic properties of soluble cytosol fractions on Meth A sarcoma cells.
    DuBois GC; Appella E; Law LW; DeLeo AB; Old LJ
    Cancer Res; 1980 Nov; 40(11):4204-8. PubMed ID: 7471061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor rejection activity of antigens isolated from the membranes of a methylcholanthrene-induced sarcoma, C-1, bearing alien H-2 antigens.
    Law LW; DuBois GC; Rogers MJ; Appella E; Pierotti MA; Parmiani G
    Transplant Proc; 1980 Mar; 12(1):46-9. PubMed ID: 6154358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.